resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
aaa66c45-c7b1-4a85-bfe9-79bb0a1334a7,SHG-140,['Cell Line'],The SHG-140 cell line was established from a glioblastoma tumor specimen obtained from a 56-year-old male patient.,['Cell line origin'],,,,https://www.doi.org/10.7150/jca.40802
aaa66c45-c7b1-4a85-bfe9-79bb0a1334a7,SHG-140,['Cell Line'],"The SHG-140 cells exhibited positive staining for markers A2B5, GFAP, Nestin, S-100, Olig2, and Ki67, indicating their glial and proliferative nature, but were negative for Vimentin.","['Cell markers', 'Proliferation']",,,,https://www.doi.org/10.7150/jca.40802
aaa66c45-c7b1-4a85-bfe9-79bb0a1334a7,SHG-140,['Cell Line'],"The SHG-140 cell line exhibited a karyotype with 55 chromosomes, including trisomies of chromosomes 6, 7, 8, 9, and X, as well as tetrasomies of chromosomes 1 and 21.",['Genomics'],,,,https://www.doi.org/10.7150/jca.40802
aaa66c45-c7b1-4a85-bfe9-79bb0a1334a7,SHG-140,['Cell Line'],"Whole oncogene sequencing of the patient tissue revealed mutations in TP53, PTEN, IDH1, and PTCH1 genes, which may be related to tumorigenesis.",['Genomics'],,,,https://www.doi.org/10.7150/jca.40802
aaa66c45-c7b1-4a85-bfe9-79bb0a1334a7,SHG-140,['Cell Line'],"The SHG-140 cells exhibited tumorigenicity when injected intracranially into nude mice, forming xenograft tumors that expressed markers like GFAP, Nestin, S-100, Olig-2, and Ki-67.","['Tumorigenicity', 'Cell markers']",,,,https://www.doi.org/10.7150/jca.40802
aaa66c45-c7b1-4a85-bfe9-79bb0a1334a7,SHG-140,['Cell Line'],"The SHG-140 cell line exhibited a slow proliferation rate within the first 48 hours of culture, followed by a rapid increase in proliferation after 48 hours.",['Proliferation'],,48,hours,https://www.doi.org/10.7150/jca.40802
aaa66c45-c7b1-4a85-bfe9-79bb0a1334a7,SHG-140,['Cell Line'],"The SHG-140 cell line maintained a stable short tandem repeat (STR) profile across multiple passages (3rd, 13th, and 33rd generations), confirming its identity as a male glioma patient-derived cell line distinct from other cell lines in the CCTCC cell bank.","['Cell line identity', 'Genomics']",,,,https://www.doi.org/10.7150/jca.40802
